U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Disopyramide Phosphate (Norpace) Capsules
Status: Currently in Shortage
»Date first posted: 03/19/2021
»Therapeutic Categories: Cardiovascular

Expand all

Pfizer Pharmaceuticals (Revised 07/22/2022)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Norpace CR, 100 mg capsules, bottle of 100 (NDC 0025-2732-31) Available Other
Norpace CR, 150 mg capsules, bottle of 100 (NDC 0025-2742-31) Available Other
100 mg capsules, bottle of 100 (NDC 59762-0386-1) Available Other
150 mg capsules, bottle of 100 (NDC 59762-0400-1) Next Delivery & Recovery: October 2022
Norpace IR, 100 mg capsules; bottle of 100 (NDC 0025-2752-31) Available Other
Norpace IR, 150 mg capsules; bottle of 100 (NDC 0025-2762-31) Next Delivery and Estimated Recovery: September 2022

Teva Pharmaceuticals (Revised 07/01/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg capsules, bottle of 100 (NDC 0093-3127-01) Product is Available
150 mg capsules, bottle of 100 (NDC 0093-3129-01) Product is Available
Back to Top